Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Urologic Diseases 1Nephritis 1Lymphoma, Non-Hodgkin 1Kidney Diseases 1Immune System Diseases 1Heart Failure 1Glomerulonephritis, IGA 1Glomerulonephritis 1Cardiomyopathies 1Autoimmune Diseases 1

Interventions

Standard of Care 2Blood Specimen Collection 2epicatechin gallate 1Vascular Stiffness 1Valsartan 1Therapeutics 1Specimen Handling 1Restraint, Physical 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1Exercise 1Electronic Health Records 1Electrocardiography 1Echocardiography 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiomyopathies × Valsartan × Clear all
NCT00162955 2012-05-08

Prevention of CHOP-induced Chronic Cardiotoxicity

Osaka City University

Phase 4 Completed
150 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡